Liver Fibrosis Testing in Patients With Type 2 Diabetes: The Time Is Now

Mirko Zoncapè^{1

2}, Emmanuel A Tsochatzis^{1

2}

Affiliations

¹ Sheila Sherlock Liver Centre, Royal Free Hospital, London, U.K.
² UCL Institute of Liver and Digestive Health, University College London, London, U.K.

Editorial

Mirko Zoncapè et al. Diabetes Care. 2025.

. 2025 Jun 1;48(6):871-873.

doi: 10.2337/dci25-0008.

Mirko Zoncapè^{1

2}, Emmanuel A Tsochatzis^{1

2}

¹ Sheila Sherlock Liver Centre, Royal Free Hospital, London, U.K.
² UCL Institute of Liver and Digestive Health, University College London, London, U.K.

No abstract available

Comment on

Screening for Metabolic Dysfunction-Associated Steatotic Liver Disease-Related Advanced Fibrosis in Diabetology: A Prospective Multicenter Study.
Caussy C, Vergès B, Leleu D, Duvillard L, Subtil F, Abichou-Klich A, Hervieu V, Milot L, Ségrestin B, Bin S, Rouland A, Delaunay D, Morcel P, Hadjadj S, Primot C, Petit JM, Charrière S, Moulin P, Levrero M, Cariou B, Disse E. Caussy C, et al. Diabetes Care. 2025 Jun 1;48(6):877-886. doi: 10.2337/dc24-2075. Diabetes Care. 2025. PMID: 39887699